GO:0015247 aminophospholipid flippase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015247 (aminophospholipid flippase activity) is a molecular function that moves aminophospholipids from the exoplasmic to the cytosolic leaflet of a membrane using ATP hydrolysis.
• This activity establishes and maintains the asymmetric distribution of phosphatidylserine (PS) and phosphatidylethanolamine (PE) across the plasma membrane.
• Loss of aminophospholipid flippase activity causes PS exposure, a key signal for apoptotic cell clearance and a hallmark of diseases such as hereditary xerocytosis and sickle cell disease [1,4,7].
• TMEM16F (ANO6) is a calcium-activated scramblase that opposes flippase activity and is a major drug target in blood disorders [2,4,7].
• PIEZO1-TMEM16F coupling links mechanical force to lipid scrambling and is implicated in red blood cell dehydration and thrombosis [4,6,7].
• CRISPR knockout, point-mutation, knock-in and overexpression cell models are essential to dissect the causal roles of flippase and scramblase genes in disease [4,7].
Description
Aminophospholipid flippase activity (GO:0015247) is a molecular function that enables the transfer of aminophospholipids from the exoplasmic to the cytosolic leaflet of a membrane using energy from ATP hydrolysis. This activity is fundamental to the asymmetric organization of biological membranes, where phosphatidylserine (PS) and phosphatidylethanolamine (PE) are normally enriched in the inner (cytosolic) leaflet. The regulated exposure of PS on the outer leaflet is a critical signaling event in apoptosis and blood coagulation, and its dysregulation is linked to human disease [1,4]. Researchers study this term to understand how cells maintain lipid asymmetry, how this asymmetry is lost during cell death or pathological activation, and how to therapeutically target the enzymes involved [1,2,7]. The interplay between aminophospholipid flippases and calcium-activated scramblases such as TMEM16F determines the steady-state distribution of PS and PE [2,4]. Recent structural and functional studies have begun to reveal how mechanical forces and membrane contact sites regulate lipid transport, providing new angles for drug discovery [3,8].
aminophospholipid flippase activity At A Glance
| GO ID | GO:0015247 |
|---|---|
| GO term | aminophospholipid flippase activity |
| Ontology | molecular_function |
| Synonym | aminophospholipid transmembrane transporter activity; aminophospholipid transporter activity |
| Definition | Enables the transfer of aminophospholipids from the exoplasmic to the cytosolic leaflet of a membrane, using energy from the hydrolysis of ATP. |
| Major function | Maintains asymmetric distribution of phosphatidylserine and phosphatidylethanolamine across membranes. |
| Cofactor | ATP (required for hydrolysis-driven lipid transport). |
| Directionality | Exoplasmic to cytosolic leaflet (inward-directed flippase). |
What Is GO:0015247?
Aminophospholipid flippase activity (GO:0015247) is defined as the ATP-dependent transfer of aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, from the exoplasmic (outer) leaflet to the cytosolic (inner) leaflet of a membrane. This activity is a type of transmembrane transporter activity that uses the energy released by ATP hydrolysis to move lipids against their concentration gradient, thereby establishing and maintaining membrane lipid asymmetry.
Why Is aminophospholipid flippase activity Important in Cell Biology?
Aminophospholipid flippase activity is essential for cellular life because it establishes the asymmetric lipid bilayer that is required for normal membrane function, vesicle trafficking, and signal transduction. When this activity is impaired, phosphatidylserine becomes exposed on the cell surface, which can trigger blood coagulation, mark cells for phagocytic clearance, or contribute to pathological conditions such as hemolytic anemia and thrombosis [1,4,6]. Understanding this activity is therefore critical for researchers in cell biology, hematology, immunology, and drug discovery [1,2,7].
• Maintains phosphatidylserine and phosphatidylethanolamine in the inner leaflet of the plasma membrane.
• Prevents inappropriate blood coagulation by keeping procoagulant lipids inside the cell [1,6].
• Regulates apoptotic cell clearance by controlling phosphatidylserine exposure.
• Opposes calcium-activated scramblases such as TMEM16F to set the steady-state lipid distribution [2,4].
• Dysregulation is linked to hereditary xerocytosis and sickle cell disease complications [4,7].
• Mechanical force sensing via PIEZO1 can modulate lipid scrambling and flippase balance [4,7].
• TMEM16E regulates endothelial procoagulant activity and thrombosis, highlighting the importance of lipid asymmetry in vascular biology.
• Membrane contact sites mediated by IST2-OSH6 complexes reveal structural principles of lipid transport.
• TMEM63 mechanosensitive channelopathies illustrate the broader family of lipid-interacting membrane proteins.
• Provides a target for pharmacological modulation of anoctamin family proteins.
What Happens During aminophospholipid flippase activity?
Substrate recognition and binding
In simple terms: The flippase first grabs the lipid it needs to move.
Aminophospholipid flippases specifically recognize aminophospholipids such as phosphatidylserine (PS) and phosphatidylethanolamine (PE) in the exoplasmic leaflet of the membrane. This substrate specificity ensures that only aminophospholipids, and not other phospholipids like phosphatidylcholine, are transported inward. The binding step is the first committed step in the flippase catalytic cycle and is essential for maintaining lipid asymmetry.
ATP hydrolysis and conformational change
In simple terms: The flippase uses energy from ATP to change its shape and push the lipid across.
Upon substrate binding, the flippase hydrolyzes ATP to ADP and inorganic phosphate, releasing energy that drives a conformational change in the transporter. This ATP-dependent step is what distinguishes flippases from passive scramblases, which move lipids down their concentration gradient without energy input [1,2]. The energy from ATP hydrolysis is used to translocate the aminophospholipid across the lipid bilayer against its concentration gradient.
Translocation across the bilayer
In simple terms: The lipid is flipped from the outside to the inside of the membrane.
The conformational change moves the aminophospholipid from the exoplasmic leaflet to the cytosolic leaflet of the membrane. This translocation is the defining event of aminophospholipid flippase activity and results in the accumulation of PS and PE in the inner leaflet. The directionality is strictly inward (exoplasmic to cytosolic), which is critical for establishing membrane asymmetry.
Counteraction by scramblases
In simple terms: Other proteins can scramble lipids back, so the balance matters.
Calcium-activated scramblases such as TMEM16F (ANO6) move phospholipids bidirectionally across the membrane, opposing the inward-directed flippase activity [2,4]. The steady-state distribution of PS and PE therefore reflects a dynamic balance between flippase-mediated inward transport and scramblase-mediated randomization [2,4]. In platelets and red blood cells, this balance controls procoagulant activity and cell clearance [4,6].
Regulation by mechanical force and membrane contact sites
In simple terms: Physical forces and contact points between organelles can tune lipid transport.
Mechanosensitive channels such as PIEZO1 can couple mechanical force to TMEM16F-mediated lipid scrambling, thereby indirectly influencing the effective flippase-scramblase balance [4,7]. Membrane contact sites, such as those formed by the IST2-OSH6 complex, provide structural platforms for lipid transfer between organelles and may coordinate with flippase activity. These regulatory inputs allow cells to adapt lipid asymmetry in response to mechanical and metabolic cues [4,7,8].
Key Genes Involved in GO:0015247 aminophospholipid flippase activity
The following genes and proteins are experimentally linked to aminophospholipid flippase activity, its regulation, or the opposing scramblase reactions that together control membrane lipid asymmetry.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP8A1 | P4-ATPase flippase that translocates aminophospholipids | Core enzyme for studying ATP-dependent lipid asymmetry |
| ATP8A2 | P4-ATPase flippase with neuronal expression | Candidate for neurological studies of lipid asymmetry |
| ATP8B1 | P4-ATPase flippase in liver and intestine | Linked to cholestasis and lipid transport research |
| ATP11A | P4-ATPase flippase that maintains PS asymmetry | Key enzyme opposing PS exposure during apoptosis |
| ATP11C | P4-ATPase flippase in blood cells | Important for red blood cell and platelet lipid asymmetry |
| TMEM16F (ANO6) | Calcium-activated scramblase | Opposes flippase activity; drug target in blood disorders [2,4,7] |
| TMEM16E (ANO5) | Anoctamin family member regulating procoagulant activity | Endothelial cell procoagulant activity and thrombosis |
| PIEZO1 | Mechanosensitive cation channel | Couples mechanical force to TMEM16F-mediated scrambling [4,7] |
| TMEM63 | Mechanosensitive channel family | Channelopathies linked to membrane mechanics |
| IST2 | Membrane contact site protein | Structural basis for lipid transport at contact sites |
| OSH6 | Oxysterol-binding protein homolog | Forms complex with IST2 for lipid transfer |
| XK | Membrane protein in red blood cells | Potential modifier of lipid asymmetry in hematology |
| ABC1 (ABCA1) | Lipid transporter | Related to phospholipid export and membrane lipid handling |
| SCARB1 | Scavenger receptor | Lipid uptake and membrane lipid composition |
| ANO1 | Anoctamin family chloride channel | Anoctamin pharmacology and lipid interactions |
| ANO2 | Anoctamin family member | Anoctamin pharmacology |
| ANO10 | Anoctamin family member | Anoctamin pharmacology |
How Is aminophospholipid flippase activity Regulated?
Aminophospholipid flippase activity is regulated at multiple levels. Calcium signaling activates scramblases such as TMEM16F, which counteract flippase-mediated inward transport and promote PS exposure [2,4]. Mechanical force sensed by PIEZO1 can modulate TMEM16F activity, thereby indirectly influencing the effective flippase-scramblase balance [4,7]. Membrane contact sites formed by IST2-OSH6 complexes provide spatial organization for lipid transfer and may coordinate flippase function with organelle communication. Additionally, the expression of anoctamin family members and their pharmacological modulation can alter lipid scrambling and procoagulant activity [2,6].
aminophospholipid flippase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIEZO1 | Hereditary xerocytosis; sickle cell disease complications | Knock-in of gain-of-function mutations in erythroid cell lines [4,7] |
| TMEM16F (ANO6) | Blood coagulation; Scott syndrome-like phenotypes | Knockout and point-mutation models in platelets and red blood cells [2,4] |
| TMEM16E (ANO5) | Thrombosis; endothelial procoagulant activity | Endothelial cell knockout and overexpression models |
| ATP11A | Apoptosis and PS exposure | Knockout cell lines to study PS externalization |
| ATP11C | Red blood cell and platelet lipid asymmetry | Knockout mouse and cell models |
Hereditary xerocytosis and red blood cell disorders
Hereditary xerocytosis is caused by gain-of-function mutations in PIEZO1 that lead to increased TMEM16F-mediated lipid scrambling and red blood cell dehydration. Disruption of PIEZO1-TMEM16F coupling can mitigate these effects, highlighting the therapeutic potential of targeting the flippase-scramblase balance. The disease demonstrates how dysregulated lipid asymmetry directly impacts red blood cell physiology and survival.
Sickle cell disease complications
In sickle cell disease, abnormal PIEZO1-TMEM16F coupling contributes to red blood cell dehydration and other complications. Targeting this coupling has been proposed as a strategy to mitigate disease complications. These findings link aminophospholipid flippase/scramblase balance to a major hematological disorder.
Thrombosis and endothelial procoagulant activity
TMEM16E regulates endothelial cell procoagulant activity and thrombosis, indicating that anoctamin family proteins control the exposure of procoagulant lipids on the cell surface. This connects lipid asymmetry regulation to vascular disease and thrombosis. Pharmacological modulation of anoctamin proteins may therefore have antithrombotic applications [2,6].
Apoptosis and clearance of apoptotic cells
Phosphatidylserine exposure on the outer leaflet is a key signal for apoptotic cell clearance by phagocytes. Aminophospholipid flippase activity normally keeps PS inside the cell, and its inactivation during apoptosis contributes to PS exposure. Defects in this process can lead to autoimmune responses and chronic inflammation.
From aminophospholipid flippase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate flippase cause PS exposure? | CRISPR knockout cell line (e.g., ATP11A KO) |
| Does a specific point mutation alter flippase activity? | Point-mutation knock-in cell line |
| Can a disease-associated mutation be corrected? | Knock-in of wild-type or mutant allele |
| Where is the flippase localized in the cell? | Tagged knock-in with fluorescent protein |
| Does overexpression of a scramblase increase PS exposure? | Overexpression cell model |
| Can pharmacological agents modulate flippase-scramblase balance? | Knockout plus drug treatment in cell lines [2,4] |
How to Study the aminophospholipid flippase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine exposure on the outer leaflet | Apoptosis and blood cell activation |
| NBD-PS transport assay | Inward flippase-mediated lipid transport | Kinetic analysis of flippase activity |
| Calcium imaging | Intracellular calcium changes | Scramblase activation studies [2,4] |
| Patch-clamp electrophysiology | Ion channel activity of TMEM16 and PIEZO1 | Mechanistic studies of lipid-protein coupling [2,4] |
| Cryo-EM | Three-dimensional protein structure | Structural basis of lipid transport |
| CRISPR knockout screening | Gene requirement for lipid asymmetry | Identification of novel flippase regulators |
| Proteomics | Protein interactions and post-translational modifications | Mapping flippase complexes |
| RNA-seq | Transcriptional changes in lipid transporters | Expression profiling in disease models |
Annexin V binding assay
Annexin V binding to exposed phosphatidylserine is a standard method to measure loss of aminophospholipid flippase activity or increased scramblase activity. This assay can be performed by flow cytometry or fluorescence microscopy and is widely used to study apoptosis and blood cell activation [1,4].
Fluorescent lipid transport assays
Fluorescently labeled aminophospholipid analogs such as NBD-PS can be used to track inward flippase-mediated transport in live cells. This method allows kinetic analysis of flippase activity and its regulation by ATP and calcium [1,2].
Electrophysiology and calcium imaging
Calcium imaging and patch-clamp electrophysiology are used to study TMEM16F and other anoctamin family members that regulate scramblase activity [2,4]. These methods help dissect the calcium dependence of lipid scrambling and its coupling to flippase function [2,4].
Structural biology and membrane contact site analysis
Structural studies of IST2-OSH6 complexes and mechanosensitive channels provide mechanistic insights into lipid transport at membrane contact sites [3,8]. Cryo-EM and related techniques reveal how these proteins interact with lipids and with each other.
How CRISPR Can Be Used to Study GO:0015247 aminophospholipid flippase activity
Knockout
CRISPR knockout of candidate flippase genes such as ATP11A or ATP11C allows researchers to test whether loss of the enzyme causes phosphatidylserine exposure and impaired lipid asymmetry. Knockout cell lines are also used to study the contribution of scramblases like TMEM16F to disease phenotypes.
Point Mutation
Point-mutation knock-in models can replicate disease-associated mutations in PIEZO1 or TMEM16F to study their effects on lipid scrambling and red blood cell physiology [4,7]. These models are essential for distinguishing gain-of-function from loss-of-function mechanisms.
Knock-in
Knock-in of tagged or reporter alleles enables visualization of flippase localization and dynamics in live cells. This approach can also be used to correct disease mutations or to introduce specific regulatory elements.
Overexpression
Overexpression of scramblases such as TMEM16F or of flippases can be used to probe the effects of altered lipid transport on membrane asymmetry and cell behavior [2,4]. Overexpression models are particularly useful for pharmacological studies of anoctamin family proteins.
How EDITGENE Supports aminophospholipid flippase activity Research
Researchers studying aminophospholipid flippase activity-related genes often need to determine whether a candidate gene is causally involved in lipid asymmetry, disease phenotypes, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for aminophospholipid flippase activity research.
Frequently Asked Questions About aminophospholipid flippase activity
What is aminophospholipid flippase activity?
Aminophospholipid flippase activity (GO:0015247) is an ATP-dependent molecular function that moves aminophospholipids such as phosphatidylserine and phosphatidylethanolamine from the exoplasmic to the cytosolic leaflet of a membrane.
What genes are involved in aminophospholipid flippase activity?
Genes encoding P4-ATPases such as ATP8A1, ATP8A2, ATP8B1, ATP11A, and ATP11C are directly involved in aminophospholipid flippase activity, while TMEM16F and PIEZO1 regulate the opposing scramblase reaction [1,2,4].
What is the difference between a flippase and a scramblase?
Flippases use ATP to move aminophospholipids inward, while scramblases such as TMEM16F move lipids bidirectionally and are often activated by calcium [1,2].
How is aminophospholipid flippase activity measured?
Common methods include Annexin V binding to detect phosphatidylserine exposure and fluorescent lipid transport assays using NBD-PS.
What diseases are linked to aminophospholipid flippase dysfunction?
Dysregulation of lipid asymmetry is linked to hereditary xerocytosis, sickle cell disease complications, thrombosis, and defective apoptotic cell clearance [1,4,6,7].
What is the role of TMEM16F in lipid scrambling?
TMEM16F (ANO6) is a calcium-activated scramblase that opposes flippase activity and promotes phosphatidylserine exposure in platelets and red blood cells [2,4].
How does PIEZO1 affect aminophospholipid flippase activity?
PIEZO1 is a mechanosensitive channel that couples mechanical force to TMEM16F-mediated lipid scrambling, indirectly influencing the flippase-scramblase balance [4,7].
Can CRISPR be used to study aminophospholipid flippase activity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to dissect the roles of flippase and scramblase genes in lipid asymmetry and disease [1,4,7].
What are the synonyms for aminophospholipid flippase activity?
The synonyms are aminophospholipid transmembrane transporter activity and aminophospholipid transporter activity.
Why is phosphatidylserine exposure important?
Phosphatidylserine exposure on the outer leaflet serves as a signal for apoptotic cell clearance and promotes blood coagulation, making it critical in both physiology and disease [1,6].
Conclusion
Aminophospholipid flippase activity (GO:0015247) is a fundamental ATP-dependent molecular function that maintains the asymmetric distribution of phosphatidylserine and phosphatidylethanolamine across cellular membranes. Its balance with calcium-activated scramblases such as TMEM16F is critical for apoptosis, blood coagulation, and red blood cell physiology, and its dysregulation contributes to hereditary xerocytosis, sickle cell disease complications, and thrombosis [1,4,6,7]. Continued research using CRISPR-engineered cell models will further clarify the causal roles of flippase and scramblase genes and may reveal new therapeutic opportunities [2,4,7].
References
- 1. Nagata S. 2018. Apoptosis and Clearance of Apoptotic Cells.. Annu Rev Immunol 36:489-517 PMID: 29400998
- 2. Genovese M et al.. 2024. Anoctamin pharmacology.. Cell Calcium 121:102905 PMID: 38788257
- 3. Zheng W et al.. 2025. Structural and functional basis of mechanosensitive TMEM63 channelopathies.. Neuron 113(15):2474-2489.e5 PMID: 40480214
- 4. Liang P et al.. 2024. Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis.. Blood 143(4):357-369 PMID: 38033286
- 5. Deng Y et al.. 2021. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses.. EBioMedicine 70:103477 PMID: 34284174
- 6. Schmaier AA et al.. 2023. TMEM16E regulates endothelial cell procoagulant activity and thrombosis.. J Clin Invest 133(11) PMID: 36951953
- 7. Liang P et al.. 2025. Targeting PIEZO1-TMEM16F Coupling to Mitigate Sickle Cell Disease Complications.. Am J Hematol 100(12):2261-2275 PMID: 41059931
- 8. Arndt M et al.. 2025. Structural basis for lipid transport at membrane contact sites by the IST2-OSH6 complex.. Nat Struct Mol Biol 32(11):2219-2230 PMID: 40866577
